237 related articles for article (PubMed ID: 16817756)
21. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis.
Poffenberger MC; Straka N; El Warry N; Fang D; Shanina I; Horwitz MS
PLoS One; 2009 Jul; 4(7):e6207. PubMed ID: 19587788
[TBL] [Abstract][Full Text] [Related]
22. Immunopathological basis of virus-induced myocarditis.
Maier R; Krebs P; Ludewig B
Clin Dev Immunol; 2004 Mar; 11(1):1-5. PubMed ID: 15154605
[TBL] [Abstract][Full Text] [Related]
23. [Study on specificity of IgM antibody response in patients with coxsackie virus B infection].
Zhang T; Ma G; Ma L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):66-8. PubMed ID: 12526307
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain.
Girn J; Kavoosi M; Chantler J
J Gen Virol; 2002 Feb; 83(Pt 2):351-358. PubMed ID: 11807228
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis.
Corsten MF; Papageorgiou A; Verhesen W; Carai P; Lindow M; Obad S; Summer G; Coort SL; Hazebroek M; van Leeuwen R; Gijbels MJ; Wijnands E; Biessen EA; De Winther MP; Stassen FR; Carmeliet P; Kauppinen S; Schroen B; Heymans S
Circ Res; 2012 Aug; 111(4):415-25. PubMed ID: 22715471
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
27. The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies.
Schwimmbeck PL; Bigalke B; Schulze K; Pauschinger M; Kühl U; Schultheiss HP
Med Microbiol Immunol; 2004 May; 193(2-3):115-9. PubMed ID: 14760530
[TBL] [Abstract][Full Text] [Related]
28. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects.
Klingel K; Rieger P; Mall G; Selinka HC; Huber M; Kandolf R
Lab Invest; 1998 Oct; 78(10):1227-37. PubMed ID: 9800948
[TBL] [Abstract][Full Text] [Related]
29. Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency.
Beck MA; Williams-Toone D; Levander OA
Free Radic Biol Med; 2003 May; 34(10):1263-70. PubMed ID: 12726914
[TBL] [Abstract][Full Text] [Related]
30. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.
Opavsky MA; Martino T; Rabinovitch M; Penninger J; Richardson C; Petric M; Trinidad C; Butcher L; Chan J; Liu PP
J Clin Invest; 2002 Jun; 109(12):1561-9. PubMed ID: 12070303
[TBL] [Abstract][Full Text] [Related]
31. Molecular mapping of autoimmune B cell responses in experimental myocarditis.
Krebs P; Kurrer MO; Kremer M; De Giuli R; Sonderegger I; Henke A; Maier R; Ludewig B
J Autoimmun; 2007 Jun; 28(4):224-33. PubMed ID: 17336498
[TBL] [Abstract][Full Text] [Related]
32. Interesting problems in enteroviral inflammatory heart disease.
Tracy S; Hufnagel G; Chapman N
Herz; 1992 Apr; 17(2):79-84. PubMed ID: 1374357
[TBL] [Abstract][Full Text] [Related]
33. [Enteroviral myocarditis and dilated cardiomyopathy].
Kandolf R
Med Klin (Munich); 1998 Apr; 93(4):215-22. PubMed ID: 9594530
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of coxsackievirus B2 in mice: characterization of clinical isolates of the coxsackievirus B2 from patients with myocarditis and aseptic meningitis in Korea.
Hong J; Kang B; Yeo S; Jee Y; Park JH
J Vet Sci; 2017 Dec; 18(4):457-464. PubMed ID: 28384999
[TBL] [Abstract][Full Text] [Related]
35. The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity.
Richer MJ; Horwitz MS
J Innate Immun; 2009; 1(5):421-34. PubMed ID: 20375600
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
37. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
Horwitz MS; Ilic A; Fine C; Sarvetnick N
J Autoimmun; 2005 Sep; 25(2):102-11. PubMed ID: 16011890
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis, diagnosis and therapy of heart disease caused by enteroviruses (molecular biological study)].
Klingel K; Selinka HC; Zell R; Mall G; Bultmann B; Kandolf R
Patol Fiziol Eksp Ter; 1998; (1):5-10. PubMed ID: 9542396
[TBL] [Abstract][Full Text] [Related]
39. Aberrant PD-1 ligand expression contributes to the myocardial inflammatory injury caused by Coxsackievirus B infection.
Wang T; Chen S; Wang X; Huang Y; Qiu J; Fei Y; Chaulagain A; Chen Y; Wang Y; Lin L; Yan B; Wang Y; Wang W; Zhao W; Zhong Z
Antiviral Res; 2019 Jun; 166():1-10. PubMed ID: 30904424
[TBL] [Abstract][Full Text] [Related]
40. T cells in coxsackievirus-induced myocarditis.
Huber S
Viral Immunol; 2004; 17(2):152-64. PubMed ID: 15279696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
